insights_auto
Why is ARGX down 15.86%?
Dive Deeperchevron_right
ARGX:EBR
argenx SE
€705.60
arrow_downward
-15.86%(-133.00) 1D
Oct 8, 5:36:43 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
€749.00
High
€749.00
Low
€682.00
Mkt. cap
45.88B
Avg. vol.
71.79K
Volume
429.51K
P/E ratio
30.18
52-wk high
€925.00
52-wk low
€568.40
EPS
€23.38
Shares outstanding
35.93M
No. of employees
2K
Open
€749.00
High
€749.00
Low
€682.00
Mkt. cap
45.88B
Avg. vol.
71.79K
Volume
429.51K
P/E ratio
30.18
52-wk high
€925.00
52-wk low
€568.40
EPS
€23.38
Shares outstanding
35.93M
No. of employees
2K
News stories
From web sources and news partners
Barchart.com
·
28 minutes ago
ARGX Stock Sinks as Argenx Scraps Late-Stage Trial
KSL
·
39 minutes ago
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble
Morningstar
·
57 minutes ago
argenx Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into argenx (ARGX)
TradingView
·
2 hours ago
argenx SE Stock 12‑Month Price Target Cut to $1192.11, Implies 28% Upside
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE